F-star Therapeutics, Inc. Insider Trading for November 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in F-star Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in F-star Therapeutics, Inc. for November 2016.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 23 2016 | SBPH | Spring Bank Pharma ... | Freve Jonathan | CFO, Treasurer & Se ... | Option Exercise | A | 10.79 | 5,482 | 59,151 | 5,482 | |
Nov 23 2016 | SBPH | Spring Bank Pharma ... | Freve Jonathan | CFO, Treasurer & Se ... | Grant | A | 9.12 | 5,482 | 49,996 | 7,482 | 2 K to 7.5 K (+274.10 %) |
Nov 23 2016 | SBPH | Spring Bank Pharma ... | Afdhal Nezam H. | Chief Medical Offic ... | Option Exercise | A | 10.79 | 13,150 | 141,889 | 13,150 | |
Nov 23 2016 | SBPH | Spring Bank Pharma ... | Afdhal Nezam H. | Chief Medical Offic ... | Grant | A | 9.12 | 13,150 | 119,928 | 53,300 | 40.2 K to 53.3 K (+32.75 %) |
Nov 23 2016 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Option Exercise | A | 10.79 | 21,900 | 236,301 | 21,900 | |
Nov 23 2016 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Grant | A | 9.12 | 21,900 | 199,728 | 46,400 | 24.5 K to 46.4 K (+89.39 %) |
Nov 23 2016 | SBPH | Spring Bank Pharma ... | Arkowitz David | Director | Option Exercise | A | 10.79 | 4,386 | 47,325 | 4,386 | |
Nov 23 2016 | SBPH | Spring Bank Pharma ... | Arkowitz David | Director | Grant | A | 9.12 | 4,386 | 40,000 | 16,886 | 12.5 K to 16.9 K (+35.09 %) |
Nov 23 2016 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Option Exercise | A | 10.79 | 10,964 | 118,302 | 10,964 | |
Nov 23 2016 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Grant | A | 9.12 | 10,964 | 99,992 | 10,964 | 0 to 11 K |
Nov 23 2016 | SBPH | Spring Bank Pharma ... | Eichler Kurt M | Director | Option Exercise | A | 10.79 | 64,100 | 691,639 | 64,100 | |
Nov 23 2016 | SBPH | Spring Bank Pharma ... | Eichler Kurt M | Director | Grant | A | 9.12 | 64,100 | 584,592 | 502,090 | 438 K to 502.1 K (+14.64 %) |
Nov 10 2016 | SBPH | Spring Bank Pharma ... | Eichler Kurt M | Director | Buy | P | 8.69 | 7,000 | 60,830 | 437,990 | 431 K to 438 K (+1.62 %) |
Nov 10 2016 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Buy | P | 8.84 | 2,000 | 17,680 | 24,500 | 22.5 K to 24.5 K (+8.89 %) |